Genomics (4195) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 基米-創

Genomics (4195) reported revenue of NT$42.4 million for Oct 2026, -12.8% year on year and -56.7% from the previous month. Revenue for Jan–Oct 2026 was NT$563.1 million (+4.9% year on year).

In Oct 2026, it ranked No. 104 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$39.9 million24/10Nov 2024 NT$53.1 millionDec 2024 NT$61.4 millionJan 2025 NT$23.9 millionFeb 2025 NT$43.1 million25/02Mar 2025 NT$54.7 millionApr 2025 NT$54 millionMay 2025 NT$69.6 millionJun 2025 NT$64.9 million25/06Jul 2025 NT$48 millionAug 2025 NT$72 millionSep 2025 NT$58 millionOct 2025 NT$48.7 million25/10Nov 2025 NT$59.9 millionDec 2025 NT$111.5 millionJan 2026 NT$42.8 millionFeb 2026 NT$37.3 million26/02Mar 2026 NT$71.6 millionApr 2026 NT$46.2 millionMay 2026 NT$50 millionJun 2026 NT$72.1 million26/06Jul 2026 NT$52.1 millionAug 2026 NT$50.4 millionSep 2026 NT$98.1 millionOct 2026 NT$42.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$42.4 million-12.8%-56.7%
Sep 2026NT$98.1 million+69.1%+94.5%
Aug 2026NT$50.4 million-30.0%-3.2%
Jul 2026NT$52.1 million+8.5%-27.8%
Jun 2026NT$72.1 million+11.2%+44.4%
May 2026NT$50 million-28.2%+8.2%
Apr 2026NT$46.2 million-14.5%-35.5%
Mar 2026NT$71.6 million+30.9%+91.9%
Feb 2026NT$37.3 million-13.5%-12.8%
Jan 2026NT$42.8 million+79.3%-61.6%
Dec 2025NT$111.5 million+81.5%+86.1%
Nov 2025NT$59.9 million+12.8%+23.0%
Oct 2025NT$48.7 million+22.1%-16.0%
Sep 2025NT$58 million+12.1%-19.5%
Aug 2025NT$72 million+74.6%+50.0%
Jul 2025NT$48 million+19.3%-26.0%
Jun 2025NT$64.9 million+42.6%-6.8%
May 2025NT$69.6 million—+28.9%
Apr 2025NT$54 million—-1.3%
Mar 2025NT$54.7 million—+26.9%
Feb 2025NT$43.1 million—+80.7%
Jan 2025NT$23.9 million—-61.1%
Dec 2024NT$61.4 million+52.0%+15.6%
Nov 2024NT$53.1 million+46.4%+33.1%
Oct 2024NT$39.9 million+30.2%-22.9%

Jan–Oct 2026 cumulative: NT$563.1 million (+4.9% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Genomics vs PEC / Genomics vs Lotus Pharm / Genomics vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16